Last Updated on June 25, 2026 by Dr. Bhagat
JOURNAL METRICS·Updated June 2026
Nature Medicine Impact Factor 2025 is 52.5 (Q1, Medicine, SCIE). Published by Springer Nature since 1995. Full JCR data and submission guide.
Key Takeaways
- Nature Medicine IF 2025 is 52.5 (Q1, Medicine, SCIE)
- Published by Springer Nature
- ISSN: 1078-8956 (Print) / 1546-170 (Online)
- Established: 1995
Nature Medicine is a monthly research journal published by Springer Nature. Founded in 1995, it is one of the most influential biomedical research journals in the world, publishing original research articles, reviews, and news across the full spectrum of translational and clinical medicine. Its 2024 Journal Impact Factor is 52.5, placing it in Q1 in the Medicine, Research & Experimental category.
Key Takeaways
- Impact Factor 2024: 52.5 (JCR Q1, Medicine, Research & Experimental)
- Publisher: Springer Nature, based in London, United Kingdom
- Established: 1995
- Publication frequency: Monthly
- Scope: Translational medicine, gene and cell therapy, immunotherapy, neuroscience, metabolic disease, cancer biology, infectious diseases, cardiovascular medicine, and clinical trials
OVERVIEWNature Medicine Journal Details
| Publisher | Springer Nature |
|---|---|
| ISSN | 1078-8956 |
| eISSN | 1546-170X |
| Publication Frequency | Monthly |
| Language | English |
| Country | United Kingdom |
| First Issue | 1995 |
| Subject Category | Medicine, Research & Experimental |
| Journal Type | Research Journal |
IMPACT FACTORNature Medicine Impact Factor 2024
The 2024 Journal Impact Factor for Nature Medicine is 52.5, as reported in the 2025 Journal Citation Reports (Clarivate). The journal ranks in Q1 within the Medicine, Research & Experimental category. Nature Medicine consistently ranks among the top ten highest-impact biomedical journals globally, publishing research that bridges the gap between basic science and clinical application.
| Year | Impact Factor | JCR Category | Quartile |
|---|---|---|---|
| 2024 | 52.5 | Medicine, Research & Experimental | Q1 |
| 2023 | 58.7 | Medicine, Research & Experimental | Q1 |
| 2022 | 54.6 | Medicine, Research & Experimental | Q1 |
| 2021 | 53.4 | Medicine, Research & Experimental | Q1 |
SCOPUS METRICSNature Medicine CiteScore and SCImago
Nature Medicine is indexed in Scopus where it maintains one of the highest CiteScores in clinical medicine. The SCImago Journal Rank (SJR) reflects the journal’s unparalleled influence in translational research.
| Year | SCImago Journal Rank (SJR) |
|---|---|
| 2021 | 17.500 |
| 2022 | 18.200 |
| 2023 | 19.100 |
EDITORIAL FOCUSScope and Aims of Nature Medicine
Nature Medicine publishes original research of the highest quality that addresses the causes, mechanisms, diagnosis, and treatment of human disease. The journal covers:
- Gene and cell therapy
- Immunotherapy and vaccine development
- Cancer biology and targeted therapeutics
- Neurodegenerative and neurological disorders
- Metabolic and cardiovascular diseases
- Infectious diseases and global health
- Regenerative medicine and tissue engineering
- Medical genetics and genomics
- Drug discovery and development
- Clinical trials and biomarkers
PEER REVIEWNature Medicine Acceptance Rate and Review Process
Nature Medicine is one of the most selective biomedical journals. The editorial team evaluates all submissions for clinical relevance, originality, and broad interest to the biomedical community. Only manuscripts representing major advances in understanding or treating human disease are sent for external peer review. The acceptance rate is very low, consistent with the journal’s position among the elite tier of clinical research publications.
SUBMISSIONNature Medicine Submission Guidelines
Manuscripts are submitted through the Springer Nature online submission system. The journal considers original research articles, reviews, perspectives, and news and views. All clinical studies must adhere to ethical guidelines and include appropriate regulatory approvals. Article processing charges apply for accepted manuscripts.
| Submission to First Decision | ~7-10 days (initial editorial screening) |
|---|---|
| Peer Review Duration | ~45-60 days |
| Acceptance to Publication | ~15-30 days |
| Article Processing Charge | ~EUR 9,500 (research articles) |
INDEXINGAbstracting and Indexing
Nature Medicine is indexed in major bibliographic databases including:
- Science Citation Index Expanded (SCIE)
- Journal Citation Reports (JCR)
- Scopus
- PubMed/MEDLINE
- Google Scholar
- BIOSIS Previews
CONTACTNature Medicine Editorial Office
The editorial office of Nature Medicine is located at Springer Nature’s headquarters in London, United Kingdom.
| Publisher | Springer Nature |
|---|---|
| Address | The Campus, 4 Crinan Street, London N1 9XW, United Kingdom |
| Country | United Kingdom |
| Website | nature.com/nm |
FAQSFrequently Asked Questions
What is the Impact Factor of Nature Medicine 2024?
The 2024 Impact Factor of Nature Medicine is 52.5, according to the 2025 Journal Citation Reports by Clarivate. It ranks in Q1 in the Medicine, Research & Experimental category.
Is Nature Medicine a Q1 journal?
Yes, Nature Medicine is a Q1 journal in the Medicine, Research & Experimental category according to the Journal Citation Reports (JCR).
Who publishes Nature Medicine?
Nature Medicine is published by Springer Nature, headquartered in London, United Kingdom.
When was Nature Medicine established?
Nature Medicine was founded in 1995 and has since become one of the most cited and influential journals in translational and clinical medicine.
Is Nature Medicine indexed in PubMed?
Yes, Nature Medicine is indexed in PubMed/MEDLINE, Science Citation Index Expanded (SCIE), Scopus, and Google Scholar.
